Remdesivir reduced mortality in immunocompromised patients hospitalized for COVID-19 across variant waves: Findings from routine clinical practice

By sjmartinez • August 10, 2023

Mozaffari E, Chandak A, Gottlieb RL, Chima-Melton C, Read SH, Jiang H, Chiang M, Lee E, Gupta R, Berry M, Kalil AC. Remdesivir reduced mortality in immunocompromised patients hospitalized for COVID-19 across variant waves: Findings from routine clinical practice. Clin Infect Dis. 2023 Aug 9:ciad460. doi: 10.1093/cid/ciad460. Epub ahead of print. PMID: 37556727.

Tags: comparative effectiveness research, covid-19, immunocompromised, mortality, Publications, Pulmonary, Critical Care & Sleep Medicine, remdesivir, survival

Multicytokine-based transcriptome-wide association study for 7 inflammatory skin disorders identifies candidate causal genes in keratinocytes

Zhang H, Patrick MT, Sarkar MK, Bogle R, Li Q, Uppala R, Perez White BE, Petukhova L, Dand N, Stuart PE, Christiano AM, Simpson MA,[...]

Mpox seroprevalence among sex workers and men who have sex with men preceding sustained urban outbreak in the Democratic Republic of the Congo

Mukadi PK, Merritt S, Nkuba-Ndaye A, Halbrook M, Anta Y, Bodisa Matamu T, Hasivirwe Vakaniaki E, Mukadi-Bamuleka D, Harrigan RJ, Lunyanga L, Kacita C, Kompany[...]

SARS-CoV-2 nucleocapsid induces hyperinflammation and vascular leakage through the Toll-like receptor signaling axis in macrophages

Yao Z, Alvarez PA, Chavez C, Delgado Y, Kaushal P, Buchholz DW, Austin D, Li Q, Yu Y, Zaiss AK, Arumugaswami V, Ding Q, Hsu[...]